SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

NCT06614322 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

190

Enrollment

OTHER

Sponsor class

Conditions

Painful Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain (DPN)
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Idiopathic Peripheral Neuropathy

Interventions

DRUG: Pregabalin
DRUG: Duloxetine
OTHER: Placebo

Sponsor

University of Rochester

Collaborators

[object Object]